Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor Pleiotropic Effects in ACS PCI
NCT01626534Phase 3Completed
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Mar 2012
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in acute coronary syndrome (ACS), sponsored by Assistance Publique-Hôpitaux de Marseille. Started Mar 2012; status: completed.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT01626534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01626534.